Chuanxiang Chi, MD
Physical Medicine & Rehabilitation · Forest Hills, NYNPI 1609985506
Payments from drug & device makers
Across 31 payments — averaging $78.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$265
- Incyte Corporation$250
- Exelixis Inc.$222
- Amgen$218
- Gilead$194
- Johnson & Johnson$150
- plus $1K from 12 others
What the payments were for
- Food & beverage$2,425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 2 | $265 |
| Incyte Corporation | 2 | $250 |
| Exelixis Inc. | 2 | $222 |
| Amgen(2 entities) | 7 | $218 |
| Gilead | 2 | $194 |
| Johnson & Johnson(2 entities) | 2 | $150 |
| IBSA Pharma Inc. | 1 | $125 |
| Bayer | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Beigene USA, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $116 |
| AbbVie | 1 | $112 |
| Boehringer Ingelheim | 1 | $111 |
| Bioventus LLC | 3 | $100 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| UCB, Inc. | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,425 in reported general payments places this provider in the 85th percentile of 872 physical medicine & rehabilitation providers in New York.
See all physical medicine & rehabilitation providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Epolamine | 404 | $250,952 |
| Diclofenac Sodium | 301 | $50,234 |
| Lidocaine | 53 | $3,964 |
| Celecoxib | 117 | $1,174 |
| Gabapentin | 213 | $1,127 |
| Meloxicam | 472 | $1,055 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 13 | $533 |
| Naproxen | 90 | $524 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 26 | $503 |
| Omeprazole | 40 | $461 |
| Triamcinolone Acetonide | 11 | $386 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $319 |
| Cyclobenzaprine Hcl | 42 | $233 |
| Procto-Med HcHydrocortisone | 12 | $233 |
| Esomeprazole Magnesium | 12 | $173 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Forest Hills
- Margarita NunezStaten Island$2M
- Heakyung KimNew York$453K
- Jeffrey BazarianRochester$430K
- Mary WelchBuffalo$349K
- Joan StillingNew York$332K
- Michael OdellNew York$297K
- Yuxi ChenBronx$295K
- Heidi FuscoNew York$221K
- Jeffrey WeinbergStaten Island$85K
- Geraldine DapulRochester$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.